Impact of Curcuma mangga Val. Rhizome Essential Oil to p53, Bcl-2, H-Ras and Caspase-9 expression of Myeloma Cell Line by Astuti, Endang et al.
I.J. Biotech.
23
Astuti et al
Impact of Curcuma mangga Val. Rhizome Essential Oil to p53, Bcl-2, H-Ras 
and Caspase-9 expression of Myeloma Cell Line
Endang Astuti1, Retno Sunarminingsih2, Umar Anggara Jenie2, Sofi a Mubarika3 and 
Sismindari2
1Doctor Candidate, Biotechnology Study Program, Universitas Gadjah Mada, Yogyakarta
2Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta
3Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta
Abstract
Cancer is a disease, a public health problem, which is found in the world as well as in Indonesia. In 
general, some of cancer theraphies are ineffective, characterized by the resistance performance of cancer cell line, 
the exposed normal cell and by the side effects. Nowadays, studies to fi nd the specifi c and safely anti-cancer 
drugs were increased by the time. Several studies revealed that Curcuma mangga Val. Rhizome contains some 
secondary metabolites, essential or non-essential oil, which has cytotoxic activities to the cancer cells. Based 
on these anti-cancer potentials, this study has several aims to recognize anti-cancer selectivity and molecular 
mechanism by inducting apoptosis and inhibiting myeloma cell proliferation. To C. mangga Val. essential oil, 
immunocyto chemical test was performed to determine the expression of p53, caspase-9, Bcl-2, H-Ras protein 
while TUNEL test was performed to determine the number of apoptosis cells. 
The results of this study shown that anti-cancer molecular mechanism of C. mangga Val. essential oil to 
myeloma cell line was performed by increasing apoptosis; by increasing the expression of pro-apoptosis p53, 
caspase-9 protein and reducing protein which is increasing proliferation Bcl-2 and H-Ras.
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Introduction
Several studies of C. mangga Val. 
revealed that C. mangga Val. contains a lot 
of non essential oil as well as the essential 
oil secondary metabolites with cytotoxic 
to cancer cell activities (Verlianara, 2004; 
Rumiyati et al., 2007). Based on the anticancer 
potent of C. mangga Val. essential oil 
secondary metabolites, a study to recognize 
the anticancer molecular action mechanism, 
by inducing apoptosis and inhibiting 
proliferation, is necessary to performed.
Cancer disease suffered since there 
is no equilibrium of cell addition rate 
(proliferation) and cell loss rate (especially 
through apoptosis). The changes occur 
since there is genetical changes especially 
on the growth gene i.e. oncogene (positive 
regulator) and oncosupressor gene (negative 
regulator). The changes of proliferation and 
apoptosis pattern could be also detected by 
observing the protein expression (Meiyanto, 
1999). Multiple myeloma (MM) is a malignant 
B cell with an accumulation plasma cell 
characteristic in spinal column, bone lesion 
and immuno-deficiention (Hallek et al, 
1998). 
B-cell lymphoma-2 (Bcl-2) protein group 
contains of pro-apoptosis and anti-apoptosis 
proteins. Anti-apoptosis containing Bcl-2, 
Bcl-XL, Bcl-W, Mcl-1, Bcl-2A1 and Bcl-B cause 
pro-apoptosis BH3-domain protein (Bim or 
tBid) inactive (Huang, 2000; Solari et al., 2002; 
Fesik, 2005; Call et al., 2008; Kang and Reynold, 
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2009; Wong, 2011l; Apraiz et al., 2011). Small 
number of p53 protein is expressed at normal 
condition (Wang et al., 2003; Lane and Levine, 
2010). Concentration of p53 protein as well 
as the activity were controlled by the cell 
pressure, i.e. DNA breakage. Ras oncogene 
contains of H-Ras, K-Ras and N-Ras coding 
protein with GTPase activity. Ras has a role 
in cell growth and controling proliferation 
as well as cell apoptosis processes (Neri et 
al., 1989). Caspase-9 is an iniciator caspase, 
and apoptosom such as a complex containing 
Apaf-1, cytochrom c and cofactor dATP/
ATP is required to activate it. Cytochrom 
c induces dATP binds to Apaf-1 (apoptotic 
protease activating factor 1) (Jiang and 
Wang, 2000). Cytochrom c has an important 
role in apoptosis, since the cytochrom 
c and dATP induce a Apaf-1/caspase-9 
complex formation, in addition activating 
caspase efector i.e. caspase-3 and caspase-7. 
CARD (N-terminal caspase-recruitment 
domain) of Apaf-1 in the apoptosom interacts 
to procaspase-9 and makes zymogene 
procaspase-9 activated. Oncoprotein Bcl-2 will 
inhibit apoptosis and avoid the cytochrom c 
extrication from mitochondria (Tait and 
Green, 2010).
To study the anticancer molecular 
mechanism of C. mangga Val. essential oil to 
myeloma cell, the immunocytochemical test 
to p53, Caspase-9 protein expression and 
apoptosis tests to recognize the impact to 
apoptosis, as well as to Bcl-2 and H-Rasprotein 
for proliferation. 
Material and Methods
Cancer cell lines: NaHCO3 (Merck), 
trypsin (Gibco), washing solution 99% 
RPMI 1640 (Roswell Park Memorial Institute 
1640)(Gibco), 1% penstrep (Penicillinand 
Streptomycin)(Gibco), culture media 
containing 89% RPMI, 1% penstrepand 
10% FBS, nitrocellulose fi lter paper 0.22 μm 
(Whatman), MTT solution i.e. MTT (3-(4,5-
dimethyltiazole-2-il)-2,5-dipheniltetrazolium 
bromide (Sigma) was diluted in PBS 
(phosphate buffer saline) at concentration of 5 
mg/ml, formazan solution 10% SDS (sodium 
dodesylsulfate)in 0.01 N HCl, yellow tip, 
blue tip (Boeco, Brand), DMSO (dimethyl 
sulphoxide) (Merck). Apoptosis tests using 
TUNEL method (terminal deoxynucleotidyl 
transferase dUTP nick-end labeling): fi xation 
reagent: 4% paraformaldehide (PFA) in PBS, 
PBS, ethanol, preparate glass containing 
APES (aminopropyl-triethoxysilane), 
TUNEL reagent i.e. TUNEL label mix 
(fluorescein-dUTPand –dNTP) and TdT 
(terminal deoxynucleotidyl transferase), anti 
fl uorescein TUNEL POD (Roche Diagnostics 
Indianapolis), Cardassian DAB Chromogene 
Substrate (Sigma), Hematoxylin (Dako), 
Xilena (Sigma). Immunocytochemical tests: 
monoclonal antibody p53, Bcl-2, Caspase-9 
and H-Ras (Lab Vission), micro platee24 
wells (Iwaki), ethanol (Merck), hydrogen 
peroxide (Merck), phosphate buffersaline 
(PBS) (Novo Castra), background erasers 
(protein blocker) (Trekkie Universal Link), 
TrekAvidin-HRP (label), Cardassian DAB 
Chromogen Substrate (Sigma), hematoxylin 
(Dako), cylene (Sigma), absolute alcohol 
(95%), aquadest, micro slide poly-L-Lysine 
(Muto Glass), deck glasses.
Rhizome and branches of C. mangga Val. 
9 month oldsamples were separated, rinsed 
and thinly sliced to enlarge the contact of 
surface area and water. In order to facilitate 
the water vapour to cell wall and evaporate 
essential oils, the samples were air dried for 3 
days. Steam distillation was then performed. 
For isolation method, water-steam distillation 
for 6 hours were used.
Apoptosis test of C. mangga Val. essential 
oil samples were performed by TUNEL 
(Terminal deoxynucleotidyl transferase 
dUTP nick end labeling) method (Negoescu 
et al., 1996). Each of 24 wells was completed 
with glass slide (object glass) and added 
with 200 μL cancer cells with density of 
20.104cells/well). In addition, plate was 
incubated at 37 °C and fl owed by 5% CO2 
for 30 minutes to promote cell attachment on 
the object glasses. As much as 300 μL media 
were added to each well and incubated at 37 
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oC with 5% CO2 for 24 h. The incubated plate 
was then added with sample at concentration 
of 500; 250; 125; 125; 62.5; 31.25 μg/mL and as 
a control cell, as much as 500 μL media were 
added to 1 well. Plate was then incubated at 
37 °C with 5% CO2for 24 h. When incubation 
completed, supernatant of each well was 
removed. The object glasses were rinsed 
three times by immersing to chamber with 
300 μL PBS, and followed with air dried. 
Cells on the object glass were fi xed using 
1mL PFA 4%, incubated for 20 minutes at 
room temperature, rinsed three times with 
1 mL PBS for 2 minutes per each rinsing. In 
addition, the object glasses were rinsed with 
1 mL ethanol 50% for 5 minutes, followed 
with 1 mL ethanol 70% for 5 minutes and 1 
mL ethanol 95% for 5 minutes, and then air 
dried. The object glasses were placed on the 
24 wells plate and stored in the freezer at -85 
oC. In addition, the object glasses were rinsed 
with sterille H2O, added with 20 μL Tunel 
label mix and TdT. The object glasses were 
placed on wet tissue as a base, closed with 
aluminum foil and incubated for 30 minutes 
at 37 oC. The object glasses were then rinsed 
with PBS two times, and deeply added with 
RNA solution, then incubated for 30 minutes 
at 37 oC. Another rinsing step with PBS was 
performed two times by adding 20 μL anti 
fl uorescence (Tunel POD) with incubation 
for 30 minutes. Afterwards, the object glasses 
were rinsed with PBS three times, and 
then excess Cardassian DAB Chromogene 
Substrate was added to each cell and keep 
for 5 minutes. The object glasses were then 
rinsed with aquadest, the cell stained was 
performed with hemaxtocylin and keep for 
30-60 seconds. The object glasses were then 
rinsed with tap water, 1%PBS solution and 
aquadest. The dried cells were then added 
with 95% ethanol. Xylene was added to 
each dried cell and covered with deck glass. 
The expression was then observed using 
light microscope. The apoptosis marked by 
dark-brown colorcell, while the un-apoptosis 
cell showed by blue color. Apoptosis cells 
percentage was then analyzed by calculating 
the number of apoptosis cells and the 
un-apoptosis cells. The calculation was 
performed by using microscope.
Immunocytochemica l  t e s t  was 
performed using p53, Bcl-2, Caspase-9 and 
H-Ras monoclonal antibody. Myeloma 
cells (density: 104/100 μL) were prepared 
in plate 96 wells, 100 μL media RPMI were 
added to one (1) well, another three wells 
added with the most sensitive of cancer cell 
extract/macerate/destilate with three (3) 
variation concentrations around of IC50 value. 
Afterwards, the plate was incubated at 37 
ºC with 5%CO2for 24 h. When incubation 
completed, media was discharged and 
the cells were removed by adding 100 μL 
trypsin, followed by re-suspension, then 
transfered to 1,5 mL micro tube, centrifuged 
at 1500 rpm for 5 min, and rinsed with 
200 μL PBS two times. The supernant was 
discharged and the precipitate was then 
re-suspended with 30 μL RPMI media.
First step of immunoctyochemical process 
in this study is myeloma cell fi xation using 
4%paraformaldehyde (PFA) for 20 min. 
Preparate was then incubated in hydrogene 
peroxide for 10-15 min. The cells were then 
rinsed with PBS two times, each for 3 min, 
added with monoclonal antibody (primary 
antibody) and incubated for 1 h at minimum, 
followed with cell rinsing by PBS four times. 
The cells were added with Biotinylated 
Goat Anti-Polyvalent (secondary antibody), 
incubated for 10 min at room temperature 
and rinsed with PBS four times. Afterwards, 
the cells were then added with Streptavidin 
Peroxidaseand also incubated for 10 min 
at room temperature, and rinsed with PBS 
four times. The cells were added with DAB 
(chromogene), incubated for 3-8 min, and 
rinsed with aquadest. The preparate was then 
embedded in hemaxtocylin for 3-4 min, rinsed 
with aquadest, and stick on the deck glass. 
Chromogene 3’-3’ diaminobenzidine (DAB) 
was used as a horseradish peroxidaseenzyme 
substrate, the product visually can be seen as 
brown color (Graham, Jr. and Karnosky, 1966). 
Peroxidase and hydrogene peroxide (H2O2) 
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Figure 1 showed that only 5.79%of myeloma 
cancer cells without C. mangga Val. essential 
oil (control) expressing Bcl-2. 
This distinction is possible since the cell 
culture has grown repeatedly, then epigenetic 
changes may occurs. The epigenetic changes 
is a spontaneous changes caused by sensitive 
cell culture to enviromental changes (Rubin, 
1993). The addition of C. mangga Val. essential 
oil at various concentrations as well as with 
various parts will only slighlty increase the 
Bcl-2 expression, therefore it is expected to 
increase the apoptosis. The low results of 
Bcl-2 expression by the addition of C. mangga 
Val. essential oil is possible caused by the 
BH3 protein activation which is inhibiting 
Bcl-2 protein anti-apoptosis or activating pro-
apoptosis protein such as Baxor Bak.
The results of p53 protein expression on 
myeloma cells are presented on Table 1,2 and 
Figure 2. The results showed that without 
any addition of C. mangga Val. essential oil, 
p53 protein was only expresseed 10.17%. 
The low of p53 expression indicates p53 gene 
mutation. This results is correspond to Ozaki 
and Nakagawara (2011) studies, which is 
found more than 50% cancer patient with p53 
gene mutation and malfunction. Mutation on 
p53 gene is usually occurs at fi nal stadium 
(fi nal level) with 20-40% prevalence which 
will inhibit apoptosis and cause MM cell 
differentiation (Hallek et al., 1998). 
Myeloma cell by the addition 250 μg/
mL of C. mangga Val. branch essential oil 
could increase the p53 protein expression to 
64.79%. By the increasing of p53 protein, it 
will oxidating DAB to brown unsoluble water 
polymer product (Dannenberg et al., 1994). 
Gene expressed cells showed a dark brown 
color, while the non-ones were blue. The 
results of immunocytochemical tests were 
presented as percentage, as a cells number 
of positive expressed gene to 100 cells 
calculation (Burry, 2010).
Results and Discussion
Results of this study are presented on 
Table 1 and 2, while the apoptosis myeloma 
cancer cell percentages by the addition of 
rhizome-branches mixture C. mangga Val. 
essential oil at various concentration are 
presented on Table 3.
In majority, MM patient (74-100%) 
and MM cancer cell have excess Bcl-2 
expression. The high concentration of Bcl-2 
protein causes MM cell be non-apoptosis and 
resistant to several medicines (Hallek et al., 
1998). However, the results on Table 2 and 
Table 2. Protein expression (%) of Bcl-2, p53, Caspase-9 and H-Ras in myeloma cell by 
the addition of rhizome-branches mixture essential oils of C. mangga Val. at various 
concentration 
Essential oil 
concentration (μg/mL)
Protein expression (%)
Bcl-2 p53 Caspase-9 H-Ras
+ - + - + - + -
Control 5.79 94.21 10.17 89.83 3.55 96.45 5.50 94.50
250 6.03 93.97 64.79 35.21 100 0 4.52 95.48
125 3.21 96.79 6.77 93.23 26.58 73.42 8.67 91.33
62.5 22.26 77.74 3.83 96.17 8.68 91.32 28.53 71.47
Note;  Sign (+) is positive expression cell (brown color)dan (-) is negative expression cell 
(blue color)
Table 1. Protein expression (%) of Bcl-2, p53, and 
Caspase-9 in myeloma cell by the addition of rhizome, 
branches, and rhizome-branches mixture essential oils 
of C. mangga Val.
Essential 
oil
Protein expression (%)
Bcl-2 p53 Caspase-9
+ - + - + -
Control 5.79 94.21 10.17 89.83 3.55 96.45
Rhizome 3.11 96.89 36.51 63.49 67.62 32.76
Branches 14.83 85.16 93.86 6.14 61.04 38.96
Mixture 26.32 73.68 70.08 29.91 33.77 66.23
Note;  Sign (+) is positive expression cell (brown color)
dan (-) is negative expression cell (blue color)
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                              (a)                                                                   (b)
                             (c)                                                                   (d)
Figure 1. Protein expression of Bcl-2 myeloma cell by adding the rhizome-branches mixture essential oils ofC. 
mangga Val., (a) control, (b) 62.5 μg/mL, (c) 125 μg/mL and (d) 250 μg/mL (200x magnifi cation). Sign (→ ) is positive 
expression cell (brown color) in cytoplasm and scale ( ⎯ ) is equal with 50 μm.
Table 3.  Myeloma apoptosis percentage by the addition 
of rhizome-branches mixture essential oils of C. mangga 
Val. at various concentrations 
Concentration essential oils 
of C. mangga Val. (μg/mL)
Apoptosis (%)
+ –
Control 0.08 99.12
500 1.53 98.47
250 16.39 83.61
125 40.38 59.62
62.5 0.07 99.93
31.25 4.01 95.99
Note; Sign (+) is positive expression cell (brown color)
dan (-) is negative expression cell (blue color)
is expected to have p53 with a function as a 
normal cell as well as apoptosis increased. 
In apoptosis, the p53 has a function 
to control Bcl-2 protein group activities, 
direct and indirectly. The Bcl-2 protein 
group controlling apoptosis by infl uencing 
mitochondria permeability and inhibiting 
cytochrome c extrication. The increasing of 
p53 expression is suppresing Bcl-2 as well 
as Bcl-xL expression and activity. Therefore 
the pro-apoptosis protein i.e. Bad, Bid, 
Baxand Bid are epressed in cytosol, and then 
transferred to mitochondria and promote 
cytochrome c extrication. Furthermore, p53 
protein inducting Bax, Puma and Noxa 
which are directly inhibit Bcl-2 (Hemann and 
Lowe, 2006), therefore the increasing of p53 
expression by the addition of C. mangga Val. 
essential oil in this study was not followed 
by the increasing of Bcl-2 expression. The 
increasing of p53 expression myeloma cell 
by the addition of C. mangga Val. essential 
oil will activate Bax protein and inhibit Bcl-2 
expression.  
Ras oncogene mutation of multiple 
myeloma (MM) patient is performed in 
N-Ras gene (32-54,5%) andK-Ras (27-54,5%), 
however there is no H-Ras mutation (Neri 
et al., 1989; Liu et al., 1996; Bezieau et al., 
2001). Different result was mentioned by 
Crowder et al. (2003), there are mutation in 
nucleotide GTP binding on H-Ras gene MM 
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Figure 2. Expression of p53 protein myeloma cell by the addition of rhizome-branches mixture essential oil, (a) 
control, (b) 62.5 μg/mL, (c) 125 μg/mL and (d) 250 μg/mL. Magnifi cation of 200x. Sign ( → ) is positive expression 
cell (brown color) in nucleous and cytoplasm and scale ( ⎯  ) is equal with 50 μm.
            (a)                                                              (b)
Figure 3. Expression of H-Ras protein myeloma cell by adding rhizome-branches mixture essential oil, (a) control, (b) 
62.5 μg/mL, (c) 125 μg/mL and (d) 250 μg/mL. Magnifi cation of 200x. Sign (→   ) is positive expression cell (brown 
color) on the cell membrane and scale (    ⎯     ) is equal with 50 μm.
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cell. Rasis anti-apoptosis and pro-apoptosis 
through different ways. Rasis pro-apoptosis 
protein will activate Raf, MEK, ERK, RSK 
which inhibiting anti-apoptosis Bad, Bcl-2 
and Bcl-xL protein activities. Contrary, as 
an anti-apoptosis protein, Ras inducting 
PI3-K and AKT which will inhibit caspase-9 
and Bad activity (Cox and Der, 2003). H-Ras 
oncogene has a function as pro-apoptosis 
protein. Activity of H-Ras pro-activity colon 
cancer cell HT29 increases with the addition 
of deaceytlation hyston (HDACi) inhibition. 
HDACiassists caspase-3, -7 and -8 activations 
(Rajasekharan and Raman, 2013). 
The study results (Table 1, 2 and Figure 
3) shown that there are no mutation on 
H-Ras gene myeloma cell since the H-Ras 
expression on the cell without any addition 
of C. mangga Val. essential oil was only 5.5% 
and the addition of C. mangga Val. essential 
oil reach of 250 μg/mL concentration was not 
increase H-Ras signifi cantly. Based on these 
results, the role of H-Rasas anti-apoptosis 
was low while it was high as pro-apoptosis 
protein on myeloma cell, without and with 
C. mangga Val. essential oil addition. 
Immunocytochemical test results of 
caspase-9 antibody are presented on Table 
1, 2 and Figure 4. The results of this study 
shown that the C. mangga Val. essential oil has 
a possibility to increase of caspase-9 expression 
in range of 3.55% without any treatment to 
100% or all of the cell express caspase-9 by the 
addition of 250 μg/mL C. mangga Val. essential 
oil. The high expression is also caused by the 
low of Bcl-2 expression (6.03% of 250 μg/
mL essential oil), therefore Bcl-2 blocks the 
cytochrom c extrication from mitochondria.
Two cell death types are apoptosis and 
necrosis. Apoptosis or cell death program is 
a program used to control the cell number 
and quality. The results of this study (Table 
 
                 (a)  (b)
 
                (c)  (d)
Figure 4. Expression of caspase 9 protein myeloma cell by adding rhizome-branches mixture essential oil, (a) control, 
(b) 62.5 μg/mL, (c) 125 μg/mL and (d) 250 μg/mL. Magnifi cation of 200x. Sign ( → ) is the positive expression cell 
(brown color) on cytoplasm and scale (  ⎯  ) is equal with 50 μm.
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 (a)  (b)
 (c)  (d)
 (e)  (f)
Figure 5. The apoptosis myeloma cell by the addition of rhizome-branches mixture essential oil, (a) control, (b) 31.25 
μg/mL (c) 62.5 μg/mL, (d) 125 μg/mL, (e) 250 μg/mL and (f) 500 μg/mL. Magnifi cation of 200x. Sign ( →  ) is the 
positive expression cell (brown color) on cytoplasm and scale ( ⎯  ) is equal with 50 μm.
3 and Figure 5) shown that no apoptosis on 
the myeloma cell without any addition of C. 
mangga Val. essential oil. 
The addition of 125 μg/mL C. mangga Val. 
essential oil causes the increasing of death cell 
40.38%, while no apoptosis induce (0.07%) at 
concentration of 62.5 μg/mL. The addition of 
62.5 μg/mL essential oil was not induce pro-
apoptosis p53 protein expression by resulting 
result only 3.5% and for caspase-9 was 8.13%. 
Beside of that, the anti apoptosis Bcl-2 protein 
expression was high enough of 22.26% and 
H-Ras was 26.58%. The main apoptosis ways 
are extrinsic and intrinsic ways (mitochondria 
way). Characteristic of intrinsic way is the 
mitochondria malfunction through cytochrom 
c extrication, caspase-9 activation, followed by 
caspase-3 and 7. In addition, by the cell surface 
activation through death receptor which is 
activating caspase-8 or caspase 10, followed by 
the increasing of caspase-3 is a characteristic of 
extrinsic way. 
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Conclutions 
 The C. mangga Val. essential oil 
increased the protein expression of pro-
apoptosis p53, caspase-9 and reduced the 
protein expression Bcl-2 and H-Ras which 
stimulate proliferation of myeloma cell line. 
The increasing of myeloma cell line apoptosis 
was observed by the addition of C. mangga 
Val. essential oil through mitochondria ways 
(intrinsic).
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